Tartaro A, Severini S, Tonni G, Magarelli N, Carriero A, Bonomo L
Istituto di Scienze Radiologiche, Università degli Studi G. D'Annunzio, Chieti.
Radiol Med. 1992 Nov;84(5):536-43.
The authors evaluated the role of GdDTPA in magnetic resonance angiography (MRA) of intracranial vessels. Fifteen patients affected with different conditions underwent MRA of intracranial vessels before and after paramagnetic contrast medium infusion. A superconductive 1.5-T magnet (Magnetom Siemens) was used, and a head circular coil, together with the 3DFT TOF technique. The enhanced exam was performed following the infusion of 0.2 ml/kg of GdDTPA in about 2 minutes, with simultaneous MRA image acquisition. To compare enhanced with unenhanced images relative to signal intensity, the signal increase at the basilar artery and carotid sinus was studied, together with signal-to-noise (S/N) ratio and spatial resolution. During acquisition, enhanced MRA images at the basilar artery showed a mean intensity value of 423.8 +/- 33.2 vs 357.8 +/- 53.2 of unenhanced scans; a statistically significant difference (p < 0.05; p < 0.01) was observed in favor of enhanced images. At the carotid sinus, enhanced MRA showed 184.5 +/- 28.4 mean intensity value vs 190.5 +/- 19.8 of unenhanced exams; no statistically significant difference was observed (p < 0.05; p < 0.01) in favor of unenhanced exams. At the basilar artery the S/N ratio of baseline exams was 1.9 vs 2.2 for enhanced scans; at the carotid sinus S/N ratio was 2.4 (unenhanced) vs 2.3 (enhanced). Thus, MRA allowed better visualization of peripheral branches of arterial (95.6%) and venous vessels, which unenhanced scans always failed to depict; on the other hand, enhanced images exhibited poorer definition of arterial vessels which were never isolated from the background. The simultaneous visualization of arterial and venous vessels, of choroid plexus and mucosae, affect the quality of enhanced angiograms. At present, GdDTPA is the sole contrast medium suitable for MRA intracranial vessels even though, due to its pharmacokinetic features, it is not the optimum medium.
作者评估了钆喷酸葡胺(GdDTPA)在颅内血管磁共振血管造影(MRA)中的作用。15例患有不同疾病的患者在静脉注射顺磁性造影剂前后接受了颅内血管MRA检查。使用一台1.5T超导磁体(西门子Magnetom),以及一个头部圆形线圈,并采用三维傅里叶变换时间飞跃(3DFT TOF)技术。在约2分钟内静脉注射0.2ml/kg的GdDTPA后进行增强检查,同时采集MRA图像。为了比较增强图像与未增强图像的信号强度,研究了基底动脉和颈动脉窦处的信号增加情况,以及信噪比(S/N)和空间分辨率。在采集过程中,基底动脉增强MRA图像的平均强度值为423.8±33.2,而未增强扫描的平均强度值为357.8±53.2;观察到有利于增强图像的统计学显著差异(p<0.05;p<0.01)。在颈动脉窦处,增强MRA的平均强度值为184.5±28.4,而未增强检查的平均强度值为190.5±19.8;未观察到有利于未增强检查的统计学显著差异(p<0.05;p<0.01)。在基底动脉处,基线检查的信噪比为1.9,增强扫描为2.2;在颈动脉窦处,信噪比为2.4(未增强)对2.3(增强)。因此,MRA能够更好地显示动脉(95.6%)和静脉血管的外周分支,而未增强扫描总是无法显示这些分支;另一方面,增强图像中动脉血管与背景的区分度较差。动脉和静脉血管、脉络丛和黏膜的同时显示影响了增强血管造影的质量。目前,GdDTPA是唯一适用于颅内血管MRA的造影剂,尽管由于其药代动力学特性,它并非最佳造影剂。